{
    "2021-01-07": [
        [
            {
                "time": "2021-01-07",
                "original_text": "贝达药业(300558.SZ)提名童佳为非独立董事候选人",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "童佳",
                        "非独立董事",
                        "候选人"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-01-07",
                "original_text": "贝达药业：为提高资金使用效率 拟使用不超8亿元暂时闲置募集资金进行现金管理",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "资金使用效率",
                        "闲置募集资金",
                        "现金管理"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-07",
                "original_text": "贝达药业：拟发行H股并申请在香港联交所主板挂牌上市",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "H股",
                        "香港联交所",
                        "主板上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-07",
                "original_text": "贝达药业拟发行H股并申请在港交所主板上市",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "H股",
                        "港交所",
                        "主板上市"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-07",
                "original_text": "贝达药业(300558.SZ)：预计2021年日常关联交易总额不超5000万元",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "关联交易",
                        "总额",
                        "5000万元"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-01-07",
                "original_text": "贝达药业(300558.SZ)：拟用募集资金置换1.77亿元前期投入",
                "features": {
                    "keywords": [
                        "贝达药业",
                        "募集资金",
                        "置换",
                        "1.77亿元"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-07",
                "original_text": "午间公告2021年1月7日星期四",
                "features": {
                    "keywords": [
                        "午间公告",
                        "2021年1月7日",
                        "星期四"
                    ],
                    "sentiment_score": 0.0,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}